Navigation Links
FDA Approves New Type 2 Diabetes Drug
Date:8/1/2014

FRIDAY, Aug. 1, 2014 (HealthDay News) -- The U.S. Food and Drug Administration announced on Friday that it approved a new drug, Jardiance, to help fight type 2 diabetes.

Jardiance (empagliflozin) "can be used alone or added to existing treatment regimens to control blood sugar levels in the overall management of diabetes," Dr. Curtis Rosebraugh, director of the Office of Drug Evaluation II in the FDA's Center for Drug Evaluation and Research, said in an agency statement.

The FDA also recommended that Jardiance be used along with lifestyle changes, such as eating a healthy diet and exercising regularly. The combination of medication and lifestyle modification may improve blood sugar management for people with type 2 diabetes, they said.

Over 26 million Americans are currently affected by type 2 diabetes, which accounts for about 90 percent of cases of diabetes, according to the agency.

Jardiance, made by Connecticut-based Boehringer Ingelheim Pharmaceuticals, falls into the class of diabetes medicines known as "sodium glucose co-transporter 2 (SGLT2) inhibitors." These drugs work by stopping blood sugar, or glucose, from getting reabsorbed by the kidneys. That means that more glucose is excreted by the kidneys and blood sugar levels go down, the FDA explained. Other drugs in this class of medications include Invokana (canagliflozin) and Farxiga (dapagliflozin).

The agency said the safety and effectiveness of Jardiance was tested in seven clinical trials involving almost 4,500 people with type 2 diabetes. The studies showed that Jardiance improved blood sugar levels compared to a "dummy" placebo drug.

The drug has also been studied for use alongside other medications, such as metformin, sulfonylureas, pioglitazone (Actos) and insulin. The FDA stressed that it is ordering post-marketing studies on Jardiance, with a focus on any potential cardiovascular effects, as well as safety and effectiveness in children.

Jardiance can trigger dehydration, which can cause low blood pressure, dizziness and impaired kidney function, the FDA added. This means that elderly people and those with already impaired kidney function may be at heightened risk when taking Jardiance. The drug should not be used by people with type 1 diabetes, according to the FDA.

The most common side effects seen with Jardiance included urinary tract infections and female genital infections, the FDA said.

More information

Find out more about type 2 diabetes at the American Diabetes Association.

SOURCE: U.S. Food and Drug Administration, news release, Aug. 1, 2014

--


'/>"/>
Copyright©2014 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. FDA Approves Generic Versions of Plavix
2. FDA Approves Combo Shot for Meningitis, Hib in Kids
3. FDA Approves SonixGPS Needle Guidance Technology for Vascular Access Procedures
4. FDA Approves First New Weight-Loss Drug in More Than a Decade
5. FDA Approves 1st Pill to Help Prevent HIV Infection
6. FDA Approves 2nd New Weight-Loss Drug
7. FDA Approves Flu Vaccine for Coming Season
8. FDA Approves New Once-a-Day HIV Pill
9. FDA Approves New Type of Flu Vaccine
10. Environmental Protection Agency Approves MOMS by OdorXit as a Disinfectant
11. FDA Approves 1st Skin Patch to Combat Migraines
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Approves New Type 2 Diabetes Drug
(Date:6/25/2017)... ... ... feel-good lyric music video in Final Cut Pro X with ProLyric from Pixel Film Studios. ... lyrics to any song. ProLyric flies in the text for each section and it hovers ... modularly for optimal control. ProLyric makes editing any music video or text-based production easier than ...
(Date:6/25/2017)... ... ... Republicans in the United States Senate on Thursday released their version ... It differs significantly from the American Health Care Act, which the House passed in ... House will have to take up the Senate version as-is, if it passes. , ...
(Date:6/25/2017)... ... 25, 2017 , ... An increase in wetter weather in the Northern California ... with that; a humdinger of an allergy season. A relief from drought conditions is ... misery-causing grass and weed pollen. , “Our patients have been reporting the typical ...
(Date:6/25/2017)... New Orleans (PRWEB) , ... June 25, 2017 , ... ... ARM Meeting in New Orleans. This is a new, greatly improved version of ... of Information Act (FOIA) requests by Fred Trotter and subsequently called the the “Doctor ...
(Date:6/25/2017)... ... , ... With a heatwave currently bearing down on Northern California pushing temperatures to the maximum, ... ready is easy with laser hair removal. , The process of summer waxing and ... when all you want to do is get out, dive in and cool off. There ...
Breaking Medicine News(10 mins):
(Date:6/20/2017)... Netherlands and LAGUNA HILLS, Calif. ... the presentation of new data that validate the use ... risk stratify patients with multiple myeloma (MM). In a ... the European Hematology Association (EHA) in Madrid, ... value of MMprofiler for identifying high-risk elderly patients. ...
(Date:6/20/2017)... , June 19, 2017  Hill-Rom Holdings, Inc. (NYSE: HRC), ... and webcast on Friday, July 28, 2017, beginning at 7:30 ... Audio Only Dial-in information: To participate in the conference call, ... into the call at least 10 minutes prior to the ... 34090339.  Webcast: A ...
(Date:6/19/2017)... -- Researchers from DRUGSCAN ® and INC Research ® ... complimentary webinar titled, "Untangling methods to tamper with opioid ... on Wednesday June 28, 2017 from 12:00 PM to ... feature interviews with recreational and dependent prescription opioid abusers ... use to prepare opioid tablets for routes of administration ...
Breaking Medicine Technology: